IL26 and COVID-19: In view of the published evidence on the antimicrobial and neutrophil-mobilizing properties of IL-26, together with our recent finding that systemic IL-26 associates with hyperinflammation and tissue damage in COVID-19 (18), our novel results strongly forward IL-26 as an active player in acute COVID-19.